Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Regenicin Inc.
DescriptionAutologous kerotinocytes and fibroblasts isolated from skin on an absorbable collagen substrate
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentPreclinical
Standard IndicationBurns
Indication DetailsTreat burn wounds; Treat burns requiring skin grafting
Regulatory Designation U.S. - Orphan Drug (Treat burns requiring skin grafting)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today